FOR IMMEDIATE RELEASE
Ballerup, Denmark and Redwood City, CA, USA – September 21, 2021 – Norlase, a leader in ultra-portable laser treatment devices for retina and glaucoma diseases, announced today that the United States Patent and Trademark Office has granted patent number 11,094,321 for a first-of-its-kind “Voice Control System for Ophthalmic Laser Systems.”
The system allows physicians to control parameters for laser delivery with voice recognition technology. Norlase’s industry-first voice control feature allows doctors to stay focused on their patients during treatment rather than moving to and from the laser device – improving treatment efficiency and patient care. The voice control feature can be found on Norlase’s existing family of lasers including the LEAF slit lamp based green laser photocoagulator and the LION, the industry-first laser integrated within an indirect ophthalmoscope.
“We’re excited to be recognized for innovation within the field of ophthalmology,” says Greg Fava, Norlase Vice President, Medical Devices. “We have more patents pending in this field to improve physician and patient experiences through technology. This patent recognizes the novel aspect of how voice recognition enables doctors to focus more strongly on the patient, rather than the device.”
About Norlase
Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is comprised of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care, and physician convenience for ophthalmologists worldwide. Norlase products include its flagship product LEAF, a laser photocoagulator that’s 10x smaller than existing systems and mounts directly on the slit lamp, and LION—the first fully integrated green laser and LIO.
FOR IMMEDIATE RELEASE
Ballerup, Denmark and Redwood City, CA, USA – September 21, 2021 – Norlase, a leader in ultra-portable laser treatment devices for retina and glaucoma diseases, announced today that the United States Patent and Trademark Office has granted patent number 11,094,321 for a first-of-its-kind “Voice Control System for Ophthalmic Laser Systems.”
The system allows physicians to control parameters for laser delivery with voice recognition technology. Norlase’s industry-first voice control feature allows doctors to stay focused on their patients during treatment rather than moving to and from the laser device – improving treatment efficiency and patient care. The voice control feature can be found on Norlase’s existing family of lasers including the LEAF slit lamp based green laser photocoagulator and the LION, the industry-first laser integrated within an indirect ophthalmoscope.
“We’re excited to be recognized for innovation within the field of ophthalmology,” says Greg Fava, Norlase Vice President, Medical Devices. “We have more patents pending in this field to improve physician and patient experiences through technology. This patent recognizes the novel aspect of how voice recognition enables doctors to focus more strongly on the patient, rather than the device.”
About Norlase
Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is comprised of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care, and physician convenience for ophthalmologists worldwide. Norlase products include its flagship product LEAF, a laser photocoagulator that’s 10x smaller than existing systems and mounts directly on the slit lamp, and LION—the first fully integrated green laser and LIO.
DIDN’T FIND WHAT YOU’RE LOOKING FOR?
Let us know how we can help!
DIDN’T FIND WHAT YOU
WERE LOOKING FOR?
Let us know how we can help!
